Scientipole Capital Competitors

Nestlé Health Science is a leader in the science of nutrition, committed to redefining the management of health. We offer an extensive portfolio of science-based consumer care, medical nutrition and pharmaceutical therapies. Headquartered in Switzerland, we have more than 12,000 employees around the world, with products available in more than 140 countries. We see opportunities to improve health through nutrition everywhere. Our expertise areas of active lifestyle nutrition, including vitamins, minerals, herbals and supplements (VMHS), medical nutrition, and pharmaceutical solutions, are rooted in science and cover every facet of health: prevention, maintenance, and treatment. We are redefining the way consumers and healthcare professionals approach the management of health. With a focus on areas including food allergies, metabolic health, gastrointestinal health, healthy aging, and adult acute care, we leverage our extensive research and development networks to unlock the power of nutrition. The wide range of solutions we offer across the spectrum of life has one common denominator: science-based products that help people live their best lives.

The French Tech Acceleration team within BPI France’s Innovation Division is dedicated to investing in start-up support structures such as accelerators and startup studios. Our current strategy is to primarily focus on supporting start-up studios initiatives, especially those operating in deeptech sectors (Greentech, Medtech, Biotech, Cybersecurity, Quantum systems etc…) which require significant capital needs. Deeptech startup studios aim to create high potential start-up developing disruptive technologies mainly resulting from the research work of public laboratories. In addition, we also support other growth sectors like construction sector, industry 4.0 or e-health. With 300M€ under management, we co-invest up to 50% of the rounds, with tickets from 1M€ to 10M€. The current portfolio is composed of 7 accelerators: 1Kubator, Axeleo, Héméra, Hook Invest, Schoolab, The Refiners and Wesprint, and 5 startup studios: Alacrité, Imagination Machine, MD Start II, Quatroccento and Technofounders. ******* L’équipe French Tech Accélération (Direction Innovation de Bpifrance) a vocation d’investir dans des structures d’accélération de types accélérateurs ou startup studios. Notre stratégie actuelle consiste à investir davantage dans des startup studios, notamment ceux Deeptech (Greentech, Biotech, etc), où les besoins capitalistiques sont importants, mais aussi dans d’autres secteurs d’avenir comme l’industrie 4.0 ou bien la e-santé. Les start-up studios deeptech ont pour objectif de créer des jeunes pousses développant des innovations de rupture à fortes barrières technologiques, principalement issues des travaux de recherche des laboratoires publics. Avec 300M€ sous gestion, nous co-investisons à hauteur de maximum 50% des tours de table avec des tickets de 1M€ à 10M€. Portefeuille actuel : 1Kubator, Axeleo, Héméra, Hook Invest, Schoolab, The Refiners et WeSprint (7 accélérateurs) et Alacrité, Imagination Machine, MD Start 2, Quattrocento et Technofounders (5 studios)

Eurazeo is a leading global investment company, with a diversified portfolio of €40 billion in AUM, including €31 billion from third parties, invested in 600 companies. With its considerable private equity, private debt as well as real estate and infrastructure asset expertise, Eurazeo accompanies companies of all sizes, supporting their development through the commitment of its nearly 450 professionals and by offering deep sector expertise, a gateway to global markets, and a responsible and stable foothold for transformational growth. Its solid institutional and family shareholder base, robust financial structure free of structural debt, and flexible investment horizon enable Eurazeo to support its companies over the long term. Eurazeo has offices in Paris, New York, London, Frankfurt, Berlin, Milan, Madrid, Luxembourg, Shanghai, Seoul, Singapore, Stockholm, Sao Paulo, Tokyo and Abu Dhabi. Eurazeo is listed on Euronext Paris. *** Eurazeo est un groupe d'investissement mondial de premier plan, qui gère 40 milliards d’euros d’actifs diversifiés dont 31 milliards pour compte de tiers investis dans un portefeuille de 600 entreprises. Fort de son expertise dans le Private Equity, la dette privée et les actifs immobiliers et infrastructures, le groupe accompagne les entreprises de toute taille, mettant au service de leur développement l’engagement de ses près de 450 collaborateurs, sa profonde expertise sectorielle, son accès privilégié aux marchés mondiaux, ainsi que son approche responsable de la création de valeur fondée sur la croissance. Son actionnariat institutionnel et familial, sa structure financière solide sans endettement structurel et son horizon d’investissement flexible lui permettent d’accompagner les entreprises dans la durée. Eurazeo dispose de bureaux à Paris, New York, Londres, Francfort, Berlin, Milan, Madrid, Luxembourg, Shanghai, Séoul, Singapour, Stockholm, Sao Paulo, Tokyo et Abou Dhabi. Eurazeo est cotée sur Euronext Paris.